Nu Skin Enterprises (NUS) Given “Buy” Rating at Citigroup

Citigroup reissued their buy rating on shares of Nu Skin Enterprises (NYSE:NUS) in a research note released on Tuesday, MarketBeat Ratings reports. The brokerage currently has a $81.00 price objective on the stock, up from their prior price objective of $70.00.

A number of other brokerages have also recently issued reports on NUS. ValuEngine raised shares of Nu Skin Enterprises from a hold rating to a buy rating in a research note on Sunday, December 31st. Zacks Investment Research raised shares of Nu Skin Enterprises from a sell rating to a hold rating and set a $78.00 price objective on the stock in a research note on Saturday, December 30th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of $65.38.

Shares of Nu Skin Enterprises (NUS) opened at $72.45 on Tuesday. Nu Skin Enterprises has a 52 week low of $47.10 and a 52 week high of $73.49. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.18 and a current ratio of 1.78. The company has a market cap of $3,858.72, a P/E ratio of 25.90, a PEG ratio of 2.28 and a beta of 1.56.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.76. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The firm had revenue of $563.70 million for the quarter, compared to analysts’ expectations of $562.70 million. During the same period last year, the firm earned $0.98 earnings per share. The business’s revenue for the quarter was down 6.7% on a year-over-year basis. analysts anticipate that Nu Skin Enterprises will post 3.24 EPS for the current fiscal year.

In other Nu Skin Enterprises news, insider Joseph Y. Chang sold 36,503 shares of the stock in a transaction on Friday, November 10th. The shares were sold at an average price of $62.24, for a total value of $2,271,946.72. Following the sale, the insider now directly owns 66,563 shares in the company, valued at $4,142,881.12. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Steven Lund sold 108,132 shares of the firm’s stock in a transaction on Friday, December 22nd. The stock was sold at an average price of $68.81, for a total transaction of $7,440,562.92. Following the sale, the chairman now owns 4,769 shares in the company, valued at $328,154.89. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 257,645 shares of company stock worth $17,367,125. Insiders own 5.20% of the company’s stock.

Hedge funds have recently modified their holdings of the business. Trexquant Investment LP acquired a new stake in Nu Skin Enterprises in the 3rd quarter valued at $455,000. Convergence Investment Partners LLC increased its stake in Nu Skin Enterprises by 14.2% in the 3rd quarter. Convergence Investment Partners LLC now owns 65,602 shares of the company’s stock valued at $4,033,000 after buying an additional 8,134 shares during the last quarter. BlackRock Inc. increased its stake in Nu Skin Enterprises by 1.8% in the 2nd quarter. BlackRock Inc. now owns 6,805,093 shares of the company’s stock valued at $427,632,000 after buying an additional 121,562 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Nu Skin Enterprises by 5.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,416,305 shares of the company’s stock valued at $87,443,000 after buying an additional 66,986 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its stake in Nu Skin Enterprises by 10.0% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 332,108 shares of the company’s stock valued at $20,418,000 after buying an additional 30,285 shares during the last quarter. Hedge funds and other institutional investors own 77.52% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Nu Skin Enterprises (NUS) Given “Buy” Rating at Citigroup” was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.com-unik.info/2018/01/26/nu-skin-enterprises-nus-given-buy-rating-at-citigroup.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit